Vitamin D Receptor Gene ApaI Polymorphism is Associated with Susceptibility to Colorectal Cancer

Overview

Journal Dig Dis Sci

Specialty Gastroenterology

Date 2009 Oct 2

PMID 19795209

Citations 14

Authors

Touraj Mahmoudi

Seyed Reza Mohebbi

Mohamad Amin Pourhoseingholi

Seyed Reza Fatemi

Mohammad Reza Zali

Affiliations

Soon will be listed here.

Abstract

Objectives: The purpose of this study was to investigate vitamin D receptor (VDR) gene ApaI and TaqI polymorphisms in relation to the risk of colorectal cancer (CRC) in the Iranian population.

Methods: Two single nucleotide polymorphisms in intron 8 (ApaI) and exon 9 (TaqI) of the VDR gene were genotyped in 160 subjects with CRC and 180 controls by use of the PCR-RFLP method.

Results: The VDR ApaI genotype distribution differed significantly between subjects with CRC and controls. The ApaI "aa" genotype compared with "AA" genotype was associated with a 2.3-fold increased risk of CRC (P = 0.014; OR = 2.25, 95% CI = 1.18-4.28) and the difference remained significant after adjustment for age, BMI, sex, and smoking status (P = 0.014; OR = 2.32, 95% CI = 1.19-4.54). Furthermore, the ApaI "a" allele was significantly overrepresented in subjects with CRC than controls (P = 0.014; OR = 1.48, 95% CI = 1.08-2.02).

Conclusions: These findings suggest that VDR ApaI genotype "aa" is associated with increased risk of CRC in the Iranian population. However, these data remain to be confirmed in larger studies and in other populations.

Citing Articles

A systematic review and network meta-analysis of single nucleotide polymorphisms associated with pancreatic cancer risk.

Ye Z, Li L, Luo M, Qing H, Zheng J, Zhang C Aging (Albany NY). 2020; 12(24):25256-25274.

PMID: 33226370 PMC: 7803556. DOI: 10.18632/aging.104128.

Single Nucleotide Variants Associated with Colorectal Cancer Among Iranian Patients: A Narrative Review.

Jamshidi M, Mohammadi Pour S, Mahmoudian-Sani M Pharmgenomics Pers Med. 2020; 13:167-180.

PMID: 32581566 PMC: 7280057. DOI: 10.2147/PGPM.S248349.

MicroRNA-binding site polymorphisms and risk of colorectal cancer: A systematic review and meta-analysis.

Gholami M, Larijani B, Sharifi F, Hasani-Ranjbar S, Taslimi R, Bastami M Cancer Med. 2019; 8(17):7477-7499.

PMID: 31637880 PMC: 6885874. DOI: 10.1002/cam4.2600.

Polymorphisms in Promoter Region of the Interferon-Gamma Receptor-1 Gene and its Relation with Susceptibility to Brucellosis.

Naseri Z, Bahmani N, Alikhani M, Hashemi S, Roshanaei G Iran J Pathol. 2019; 14(3):206-211.

PMID: 31582997 PMC: 6742735. DOI: 10.30699/ijp.2019.91536.1888.

Single-nucleotide polymorphism of Exo1 gene is associated with risk of colorectal cancer based on robust Bayesian approach.

Nasserinejad M, Pourhoseingholi M, Rezasoltani S, Akbari S, Baghestani A, Shojaee S Gastroenterol Hepatol Bed Bench. 2019; 11(Suppl 1):S146-S148.

PMID: 30774822 PMC: 6348001.

References

Sun G, Vasdev S, Martin G, Gadag V, Zhang H . Altered calcium homeostasis is correlated with abnormalities of fasting serum glucose, insulin resistance, and beta-cell function in the Newfoundland population. Diabetes. 2005; 54(11):3336-9. DOI: 10.2337/diabetes.54.11.3336. View

Yaylim-Eraltan I, Ergen H, Arikan S, Okay E, Ozturk O, Bayrak S . Investigation of the VDR gene polymorphisms association with susceptibility to colorectal cancer. Cell Biochem Funct. 2007; 25(6):731-7. DOI: 10.1002/cbf.1386. View

Taylor J, Hirvonen A, Watson M, Pittman G, Mohler J, Bell D . Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Res. 1996; 56(18):4108-10. View

Howard G, Nguyen T, Morrison N, Watanabe T, Sambrook P, Eisman J . Genetic influences on bone density: physiological correlates of vitamin D receptor gene alleles in premenopausal women. J Clin Endocrinol Metab. 1995; 80(9):2800-5. DOI: 10.1210/jcem.80.9.7673427. View

Kadiyska T, Yakulov T, Kaneva R, Nedin D, Alexandrova A, Gegova A . Vitamin D and estrogen receptor gene polymorphisms and the risk of colorectal cancer in Bulgaria. Int J Colorectal Dis. 2006; 22(4):395-400. DOI: 10.1007/s00384-006-0163-0. View

Lou Y, Murtola T, Tuohimaa P . Regulation of aromatase and 5alpha-reductase by 25-hydroxyvitamin D(3), 1alpha,25-dihydroxyvitamin D(3), dexamethasone and progesterone in prostate cancer cells. J Steroid Biochem Mol Biol. 2005; 94(1-3):151-7. DOI: 10.1016/j.jsbmb.2005.01.024. View

Morrison N, Qi J, Tokita A, Kelly P, Crofts L, Nguyen T . Prediction of bone density from vitamin D receptor alleles. Nature. 1994; 367(6460):284-7. DOI: 10.1038/367284a0. View

Limburg P, Stolzenberg-Solomon R, Vierkant R, Roberts K, Sellers T, Taylor P . Insulin, glucose, insulin resistance, and incident colorectal cancer in male smokers. Clin Gastroenterol Hepatol. 2006; 4(12):1514-21. PMC: 1766481. DOI: 10.1016/j.cgh.2006.09.014. View

Guzey M, Luo J, Getzenberg R . Vitamin D3 modulated gene expression patterns in human primary normal and cancer prostate cells. J Cell Biochem. 2004; 93(2):271-85. DOI: 10.1002/jcb.20182. View

10.

Swami S, Krishnan A, Feldman D . 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells. Clin Cancer Res. 2000; 6(8):3371-9. View

11.

Li C, Li Y, Gao L, Wang Y, Zhou B, Lv M . Vitamin D receptor gene polymorphisms and the risk of colorectal cancer in a Chinese population. Dig Dis Sci. 2008; 54(3):634-9. DOI: 10.1007/s10620-008-0375-y. View

12.

Gunter M, Hoover D, Yu H, Wassertheil-Smoller S, Rohan T, Manson J . Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women. Cancer Res. 2008; 68(1):329-37. PMC: 4225702. DOI: 10.1158/0008-5472.CAN-07-2946. View

13.

Grundberg E, Brandstrom H, Ribom E, Ljunggren O, Mallmin H, Kindmark A . Genetic variation in the human vitamin D receptor is associated with muscle strength, fat mass and body weight in Swedish women. Eur J Endocrinol. 2004; 150(3):323-8. DOI: 10.1530/eje.0.1500323. View

14.

Ogunkolade B, Boucher B, Prahl J, Bustin S, Burrin J, Noonan K . Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes. 2002; 51(7):2294-300. DOI: 10.2337/diabetes.51.7.2294. View

15.

Flugge J, Krusekopf S, Goldammer M, Osswald E, Terhalle W, Malzahn U . Vitamin D receptor haplotypes protect against development of colorectal cancer. Eur J Clin Pharmacol. 2007; 63(11):997-1005. DOI: 10.1007/s00228-007-0367-4. View

16.

Ochs-Balcom H, Cicek M, Thompson C, Tucker T, Elston R, Plummer S . Association of vitamin D receptor gene variants, adiposity and colon cancer. Carcinogenesis. 2008; 29(9):1788-93. PMC: 2722851. DOI: 10.1093/carcin/bgn166. View

17.

Vandewalle B, Adenis A, Hornez L, Revillion F, Lefebvre J . 1,25-dihydroxyvitamin D3 receptors in normal and malignant human colorectal tissues. Cancer Lett. 1994; 86(1):67-73. DOI: 10.1016/0304-3835(94)90181-3. View

18.

Erben R, Soegiarto D, Weber K, Zeitz U, Lieberherr M, Gniadecki R . Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D. Mol Endocrinol. 2002; 16(7):1524-37. DOI: 10.1210/mend.16.7.0866. View

19.

Baroncelli G, Bereket A, El Kholy M, Audi L, Cesur Y, Ozkan B . Rickets in the Middle East: role of environment and genetic predisposition. J Clin Endocrinol Metab. 2008; 93(5):1743-50. DOI: 10.1210/jc.2007-1413. View

20.

Tangrea J, Helzlsouer K, Pietinen P, Taylor P, Hollis B, Virtamo J . Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control. 1997; 8(4):615-25. DOI: 10.1023/a:1018450531136. View